# STOCKHOLM 1.0
#=GF ID   Reovirus_L2_MT2
#=GF AC   PF21066.1
#=GF DE   Reovirus core-spike protein lambda-2 (L2), methyltransferase-2
#=GF AU   Moxon SJ;0000-0003-4644-1816
#=GF AU   Chuguransky S;0000-0002-0520-0736
#=GF SE   Pfam-B_7350 (release 9.0)
#=GF GA   27.00 27.00;
#=GF TC   42.80 117.70;
#=GF NC   26.70 22.90;
#=GF BM   hmmbuild HMM.ann SEED.ann
#=GF SM   hmmsearch --cpu 4 -E 1000 -Z 75585367 HMM pfamseq
#=GF TP   Domain
#=GF CL   CL0063
#=GF RN   [1]
#=GF RM   11531411
#=GF RT   Mammalian reovirus L2 gene and lambda2 core spike protein
#=GF RT   sequences and whole-genome comparisons of reoviruses type 1
#=GF RT   Lang, type 2 Jones, and type 3 Dearing. 
#=GF RA   Breun LA, Broering TJ, McCutcheon AM, Harrison SJ, Luongo CL,
#=GF RA   Nibert ML; 
#=GF RL   Virology 2001;287:333-348.
#=GF RN   [2]
#=GF RM   10801118
#=GF RT   Structure of the reovirus core at 3.6 A resolution.
#=GF RA   Reinisch KM, Nibert ML, Harrison SC;
#=GF RL   Nature. 2000;404:960-967.
#=GF DR   SO; 0000417; polypeptide_domain;
#=GF CC   Reovirus core-spike protein VP1/lambda-2 (VP1/L2) forms a
#=GF CC   pentamer that mediates enzymatic reactions in 5' capping of the
#=GF CC   viral plus-strand transcripts [1]. It forms a hollow cylinder
#=GF CC   with projecting turrets. Each VP1/L2 monomer consists of eight
#=GF CC   domains with the most N-terminal domain at the base of the
#=GF CC   turret and the most C-terminal domain at the top. This entry
#=GF CC   represents the second methyltransferase domain (MT2), which
#=GF CC   catalyses the last reaction, 2'O-methylation [2].
#=GF SQ   3
#=GS LMBD2_REOVL/801-1024  AC Q91RA6.1
#=GS VP1_AQRVG/802-1032    AC B2BND9.1
#=GS VP1_AQRVC/801-1031    AC Q8JU62.1
LMBD2_REOVL/801-1024             ASPHVCLTMM....YNFEVSSAVYDGDV..VLDLGTGPEAKILELIPPTSPVTCVDIRPTAQPSGCWNVRTT.FLELDYLSDGWITGIRGDIVTCMLSLGAAAAGKSMTFDAAFQQLVKVLTKSTANVLLIQVNCPTDVIRTIKGYLEIDQTNKRYRFPKFGRDEPYSDMDSLERICRAAWPNCSITWVPLSYDLRWTKLALLESTTLSSASVRIAELMYKYMPVMRIDIH
VP1_AQRVG/802-1032               PTEPVNVTTLVAAGYNAYVHTVITSAQPAHLFDLGTGPECRILSLVPQNTRVTMVDSRPCAELMQAYDPNTTAYEQADYTLAAFWNGRQCDAVSAIFTLGAAAASNAVTIDALLANLLPSIANAGTTRLWLQVNAPLAGPTPIPGLIDIDTRAGTYTFNNGERTEPYIDPQVMQATVLAHFPNATLSWYTLPPTCEWLDYIIGAGSSLDLSTIPTALQYSQLTPILSIDTN
VP1_AQRVC/801-1031               SSEAVPVTTLVAAGYNSFISEQTRNPNLAHLLDLGTGPECRILSLIPPTLQVTMSDARPCAELMASFDPALTAYVQGDYSTAAFWNGIRCDSATAIFTLGAAAAAAGTDLIAFVQQLIPRIVAAGGTRMWLQLNTPLYEVSSLPDLIDIDLRDRVYRFNGGERVEPYADPVPLQQAIAALLPAAALSWHTLSPTCDWLPYIIGVGSPLNLSDINTAISYSRLTPILHIDTT
#=GC seq_cons                    uSEsVsVTTLVAAGYNuaVSoslpsuslAHLLDLGTGPECRILSLIPPTopVTMVDuRPCAELMuuaDPsTTAYlQuDYooAAFWNGIRCDuVTAIFTLGAAAAususTlDAhlQQLlPsIssAGuTRLWLQVNsPLsslooIPGLIDIDpRs+sYRFNsGERsEPYuDPssLQpsltAtaPNAoLSWaTLSPTC-WLcYIIGsGSoLsLSoIsTAlpYS+LTPIL+IDTs
